Frankfurt - Delayed Quote EUR
Glycorex Transplantation AB (publ) (O33.F)
0.1765
0.0000
(0.00%)
As of 8:04:33 AM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Johan Nilsson | Acting Chief Executive Officer | 1.14M | -- | 1985 |
| Mr. Erik Melgaard Pedersen | Head of Sales | -- | -- | -- |
Glycorex Transplantation AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 20
Description
Glycorex Transplantation AB (publ), a medical technology company, focuses on transplantation, blood transfusion, and autoimmune diseases. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company's principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in Europe, Austria, Germany, the Netherlands, the United Kingdom, Canada, and Spain. Glycorex Transplantation AB (publ) was incorporated in 1995 and is headquartered in Lund, Sweden.
Corporate Governance
Glycorex Transplantation AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
GKO.F GlycoMimetics, Inc.
0.1500
-1.19%
6OP.F OSE Immunotherapeutics SA
5.46
-6.43%
CERO CERo Therapeutics Holdings, Inc.
0.4000
-11.99%
PLX Protalix BioTherapeutics, Inc.
1.5400
-2.53%
GLYC GlycoMimetics, Inc.
0.1766
-8.88%
FATE Fate Therapeutics, Inc.
1.5200
-5.00%
TGTX TG Therapeutics, Inc.
39.84
-0.55%
NTLA Intellia Therapeutics, Inc.
8.28
+2.35%
IOVA Iovance Biotherapeutics, Inc.
2.2100
+7.80%
BNTX BioNTech SE
108.97
+0.44%